Clinical Trial Update: BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of BSB-1001 in patients undergoing HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia, acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BSB-1001

Snippet

Sponsor: BlueSphere Bio, Inc | Conditions: AML, Adult Recurrent, ALL, Recurrent, Adult | Phase 1, Phase 2 | Status: RECRUITING